Chief of White House’s ‘Operation Warp Speed’ vaccine effort can keep investing in pharma firms, under IG ruling

Abstract: Advocacy groups and Democratic senators have complained that Moncef Slaoui's extensive financial interests in drug companies pose a conflict of interest.